about
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the revers...
Read More
7.74
-0.13
(-1.65%)
60,816
XNAS Volume
XNAS 09 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
CervoMed Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..